Ajit Singh – Chairman, ACG
Solid dosage forms like capsules and tablets make up over 70 percent of all medicines prescribed globally. In the view of Ajit Singh, chairman of Indian solid dosage form pioneer…
Address: Dalamal House, Nariman Point,Mumbai – 400 021, India. ,India
Tel: +91-22-3008 9444 / 45
Web: http://www.acg-world.com/
ACG Worldwide has been serving the global pharmaceutical industry for over five decades and is the second largest manufacturer of empty hard capsules in the world. The group comprises of 13 companies, including subsidiaries in China, USA, Indonesia, Brazil and Europe.
ACG Worldwide has an active presence in over 100 countries with its products and services, employing approximately 3,200 members that strive to provide world-class technology across multiple domains. We offer a complete range of solutions beginning with empty capsules; granulation and coating; capsule filling; tabletting machinery; packaging films; blister packing; carton packing; tablet tooling; camera inspection systems and end-of-line solutions. With over 20,000 machine installations worldwide, it speaks lengths of the high quality standards we follow and maintain at ACG along with complying to major international quality certifications or legislations.
ACG Worldwide is committed to delivering a high level of solid dosage form to the global pharma industry. Our research teams endeavor to develop innovative technology in order to continually give our customers the benefit of a cost competitive edge plus world-class technology. ‘SciTech Centre’, the group’s 50,000 sq. ft. R & D center located in the heart of Mumbai, is a government-recognized research institution. In the last 25 years, it has witnessed breakthroughs in dosage form development including pharmaceutical engineering and delivery systems.
Manufacturing Solutions
ACG Worldwide offers end-to-end solutions in solid dosage for the pharmaceutical, OTC and dietary supplements industry…
Packaging Solutions
Our packaging solutions include high barrier packaging films from ACG Pharmapack, blister-packing & cartoning machines from ACG Pampac and Camera inspection systems from ACG Inspection.
R & D Solutions
ACG Worldwide is committed to its customer’s from the R & D stage. It manufactures Clinicaps – capsules for clinical trials, a lab model of automatic capsule filling machine, packaging films and tablet tooling sets for R & D start-ups.
Industry
ACG Worldwide develops and helps its customers with varied solutions to meet every marketing need. Experienced personnels from ACG, work closely with their customer right from initial stage, that is understanding the requirements, to addressing the needs by offering an effective solution.
Solid dosage forms like capsules and tablets make up over 70 percent of all medicines prescribed globally. In the view of Ajit Singh, chairman of Indian solid dosage form pioneer…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching up with the Western…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching up with the Western…
Writing in the March 2022 edition of DIA’s Global Forum magazine, Ananya Chakraborty from the Vydehi Institute of Medical Sciences & Research Centre outlines the key factors behind India’s successful…
The Indian pharma market clocked up double-digit growth of around 15 percent in 2021 (compared to three percent in 2020), driven primarily – but not only – by products related…
The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15 pharma billionaires, Danish CNS firm Lundbeck’s decision to…
The latest from Indian pharma, including the year-to-year 51.5 percent growth of the pharma market in April, Lilly’s partnership with three generics makers to expand the availability of its arthritis…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in the latest national budget; predictions of rapid growth in the coming decade; Cipla’s…
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands to grow by between 12 and 14 percent in the next…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with India-developed vaccine candidates moving swiftly toward Phase I and II human trials…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and active pharmaceutical ingredients for the last month. With restrictions beginning to ease up, some manufacturing…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic pharmaceuticals market. Now accounting for over 90 percent of all prescriptions dispensed in…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions for Indian pharma manufacturers and could lead to global shortages. Shortages and Price…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the coronavirus, to regulatory reform, the spike in USFDA warning letters…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an expansion into the Australia…
See our Cookie Privacy Policy Here
